We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+23.43%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
-$5.58B
Cap. Flow
-$3.87B
Cap. Flow %
-23.65%
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$114M
2
BMY icon
Bristol-Myers Squibb
BMY
+$109M
3
TT icon
Trane Technologies
TT
+$106M
4
MSFT icon
Microsoft
MSFT
+$104M
5
MA icon
Mastercard
MA
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 13.89%
3 Financials 11.27%
4 Consumer Discretionary 8.92%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHI icon
151
D.R. Horton
DHI
$41B
$25.5M 0.16%
460,545
+428,214
+1,324% +$20.8M
COHR icon
152
Coherent
COHR
$55.2B
$25.5M 0.16%
540,368
+388,796
+257% +$15.4M
ELV icon
153
Elevance Health
ELV
$81.9B
$25.3M 0.15%
96,181
-62,846
-40% -$16.8M
NKE icon
154
Nike
NKE
$61.9B
$25.1M 0.15%
256,507
-853,872
-77% -$78.8M
WAL icon
155
Western Alliance Bancorporation
WAL
$9.07B
$25M 0.15%
659,567
-197,833
-23% -$6.92M
ADBE icon
156
Adobe
ADBE
$89.5B
$24.9M 0.15%
57,163
+9,025
+19% +$3.34M
DOOR
157
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$24.6M 0.15%
316,714
-87,037
-22% -$5.28M
ULTA icon
158
Ulta Beauty
ULTA
$20.4B
$24.3M 0.15%
119,452
-366
-0.3% -$78.7K
ALL icon
159
Allstate
ALL
$66.9B
$24.2M 0.15%
249,910
+133,212
+114% +$13.1M
CACI icon
160
CACI
CACI
$10.8B
$24.2M 0.15%
111,704
-28,128
-20% -$6.72M
SO icon
161
Southern Company
SO
$110B
$24.1M 0.15%
465,183
+293,520
+171% +$16.3M
DVA icon
162
DaVita
DVA
$15.1B
$24.1M 0.15%
304,656
-105,305
-26% -$8.22M
VTI icon
163
Vanguard Total Stock Market ETF
VTI
$654B
$24M 0.15%
153,350
-26,876
-15% -$3.96M
NXST icon
164
Nexstar Media Group
NXST
$5.6B
$24M 0.15%
286,632
-80,984
-22% -$6.09M
GLD icon
165
SPDR Gold Trust
GLD
$132B
$23.7M 0.14%
141,397
+41,487
+42% +$6.69M
MET icon
166
MetLife
MET
$61B
$23.4M 0.14%
641,652
-173,620
-21% -$6.04M
D icon
167
Dominion Energy
D
$62.5B
$23.4M 0.14%
287,843
+7,271
+3% +$583K
MMSI icon
168
Merit Medical Systems
MMSI
$4.43B
$23.4M 0.14%
511,554
+159,771
+45% +$6.45M
BERY
169
DELISTED
Berry Global Group, Inc.
BERY
$23.3M 0.14%
573,498
+572,587
+62,853% +$21.5M
PXD
170
DELISTED
Pioneer Natural Resource Co.
PXD
$23.3M 0.14%
238,881
+186,328
+355% +$16.4M
FFIV icon
171
F5
FFIV
$22.1B
$23M 0.14%
164,961
-415,373
-72% -$55.9M
BYD icon
172
Boyd Gaming
BYD
$6.47B
$23M 0.14%
1,100,397
-298,558
-21% -$5.45M
MDT icon
173
Medtronic
MDT
$107B
$23M 0.14%
250,550
-226,526
-47% -$21.7M
SYF icon
174
Synchrony
SYF
$23.7B
$22.9M 0.14%
1,034,098
-1,105,358
-52% -$21.5M
WFC icon
175
Wells Fargo
WFC
$261B
$22.8M 0.14%
892,545
-535,086
-37% -$14.6M

Similar funds

Glenmede Trust's Q2 2020 Portfolio in Review

As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.

  • Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
  • Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
  • Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
  • Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
  • Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
  • Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
  • Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.